Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Ren Fail ; 38(8): 1283-90, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27402370

RESUMO

BACKGROUND: In this study, it was aimed to determine the effects of alfuzosin on experimentally generated unilateral partial ureteropelvic junction obstruction (UPO) in rats. MATERIALS AND METHODS: Thirty Long-Evans rats were randomly allocated into five groups. In control group (C), nothing was performed; in group Sham (S) only laparotomy was done; in Alfuzosin group (A) only alfuzosin was administered for two weeks (10 mg/kg/day p.o.) without any surgery; in UPO group, unilateral UP junction obstruction was produced; and in the Group UPT (ureteropelvic obstruction + treatment), alfuzosin was administered for two weeks (10 mg/kg/day p.o.) in addition to UPO production. Renal pelvic anteroposterior diameters were determined with ultrasonography (USG) and renal arterial resistivity indexes by color Doppler USG. Urine was collected both at the beginning and at the end of the experiment for 24 h in all the groups and at the end of the experiment, blood samples were obtained. Blood and urine electrolytes and TGF-ß1, urine density, urine ß2 microglobulin levels were determined. Renal tissue samples harvested from all of the rats were histopathologically evaluated. Results were determined using one-way ANOVA t-test; p < 0.05 was accepted as significant. RESULTS: Urine density in the UPT group was lower with respect to UPO group and blood electrolytes were preserved as close to normal (p < 0.05). In the UPT group, urine TGF-ß1 and blood TGF-ß1, blood ß2 microglobulin levels and histopathologic damage scores were lower compared to the UPO group (p < 0.05). CONCLUSION: It is shown in this experimental unilateral partial UPO model that alfuzosin treatment prevents obstructive renal damage.


Assuntos
Eletrólitos/urina , Rim/patologia , Quinazolinas/administração & dosagem , Fator de Crescimento Transformador beta1/urina , Obstrução Ureteral/terapia , Microglobulina beta-2/urina , Animais , Modelos Animais de Doenças , Pelve Renal/diagnóstico por imagem , Masculino , Distribuição Aleatória , Ratos , Ratos Long-Evans , Artéria Renal/diagnóstico por imagem , Fator de Crescimento Transformador beta1/sangue , Ultrassonografia Doppler , Microglobulina beta-2/sangue
2.
J Pediatr Surg ; 43(11): 2109-11, 2008 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18970951

RESUMO

Isolated premature thelarche is a common disorder characterized by breast development, usually younger than 2 years, with no other signs of puberty. Although it is usually associated with adrenal or ovarian disorders, hypothyroidism, and use of exogenous hormones or drugs, it may also be associated with long-term use of herbal medicine. Thus, long-term use of preparations such as Foeniculum vulgare, which is used to eliminate gas and regulate intestinal function in children, may cause premature thelarche, and thus, the use of such preparations should be limited.


Assuntos
Bebidas/efeitos adversos , Foeniculum/efeitos adversos , Fitoestrógenos/efeitos adversos , Fitoterapia , Preparações de Plantas/efeitos adversos , Puberdade Precoce/induzido quimicamente , Idoso , Derivados de Alilbenzenos , Anisóis/efeitos adversos , Pré-Escolar , Estradiol/sangue , Feminino , Flatulência/tratamento farmacológico , Humanos , Lactente , Menstruação/efeitos dos fármacos , Fitoterapia/efeitos adversos , Óleos de Plantas/efeitos adversos , Preparações de Plantas/uso terapêutico , Pós-Menopausa/efeitos dos fármacos , Puberdade Precoce/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA